Argenica Therapeutics

Argenica Therapeutics was incorporated on 20/11/2019 as a proprietary Australian company to undertake the development and commercialisation of a novel drug based on the pioneering work of Professor Bruno Meloni and Clinical Professor Neville Knuckey at the University of Western Australia (UWA) and the Perron Institute for Neurological and Translational Science (Perron Institute).

Spotlight Videos

Developing therapeutics to reduce brain damage after stroke
All Argenica Therapeutics Content